In this Issue:
CD management after intestinal resection
FC for predicting relapse after stopping anti-TNF agents in IBD
Second anti-TNF efficacy after initial failure in IBD
Thiopurine withdrawal during sustained remission in IBD
Adalimumab maintenance in moderately to severely active UC
Serum infliximab concentration and efficacy in UC
CAM treatments in IBD
NMSC (not melanoma) risk increased by thiopurines in UC
Anti-TNF agents reduce radiation exposure in CD
Please login below to download this issue (PDF)